Status:
COMPLETED
Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Société de Dermatologie Française
Conditions:
Psoriasis
Eligibility:
All Genders
18-99 years
Brief Summary
PSOBIOTEQ is a national multicentric prospective non interventional study which aims to constitute a French registry of cutaneous psoriasis patients initiating systemic treatment (excluding acitretin ...
Detailed Description
PSOBIOTEQ is a national multicentric prospective non interventional study which aims to constitute a French registry of cutaneous psoriasis patients initiating systemic treatment (excluding acitretin ...
Eligibility Criteria
Inclusion
- Patient aged 18 or over
- Had been informed about the objectives and progress of the research, and not opposed to the collection of his data
- Consulting or hospitalized in one of the departments participating in the study :
- For a cutaneous psoriasis (clinical diagnosis)
- And at least one of the two criteria below must be met :
- In whom a systemic treatment is initiated (excluding phototherapy or acitretin) that he has never received in the past \* (a patient who has already received a biomedicine (princeps and / or biosimilar (s)) in the past cannot be included under the same biomedicine (princeps and / or biosimilar (s)). Patients initiating treatment with methotrexate or ciclosporin must be naïve of any biomedicine.
- Patients included in the PSOBIOTEQ 1 cohort
Exclusion
- Patient for whom cutaneous psoriasis is not the main reason for systemic treatment (psoriatic arthritis, or concomitant Crohn's disease, etc.);
- Patient unable to comply with the registry's follow-up procedures (not reachable by phone, unable to complete the self-questionnaire) or whose monitoring is deemed difficult;
- Patient for whom the treatment administered at inclusion cannot be identified (patient included in a randomized double-blind biomedicine research protocol, for example).
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
September 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04841187
Start Date
September 6 2021
End Date
December 31 2023
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Henri Mondor
Créteil, France, 94010